XML 18 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Preferred Stock
Series B preferred stock
Additional Paid in Capital.
Accumulated Deficit
Total
Balance at beginning at Sep. 30, 2021 $ 4,449 $ 20 $ 69,833,650 $ (66,842,416) $ 2,995,703
Balance at beginning (in shares) at Sep. 30, 2021 44,490,003 200,000      
Increase (Decrease) in Stockholders' Equity          
Stock-based compensation     1,549,406   1,549,406
Net loss       (4,273,995) (4,273,995)
Balance at ending (in shares) at Dec. 31, 2021 44,490,003 200,000      
Balance at ending at Dec. 31, 2021 $ 4,449 $ 20 71,383,056 (71,116,411) 271,114
Balance at beginning at Sep. 30, 2021 $ 4,449 $ 20 69,833,650 (66,842,416) 2,995,703
Balance at beginning (in shares) at Sep. 30, 2021 44,490,003 200,000      
Increase (Decrease) in Stockholders' Equity          
Payment in kind interest stock issuance         $ 177,000
Payment in kind interest stock issuance (in shares)         23,152
Net loss         $ (14,921,110)
Balance at ending (in shares) at Jun. 30, 2022 51,179,820        
Balance at ending at Jun. 30, 2022 $ 5,118   79,329,248 (81,763,526) (2,429,160)
Balance at beginning at Dec. 31, 2021 $ 4,449 $ 20 71,383,056 (71,116,411) 271,114
Balance at beginning (in shares) at Dec. 31, 2021 44,490,003 200,000      
Increase (Decrease) in Stockholders' Equity          
Stock-based compensation     1,116,318   1,116,318
Payment in kind interest stock issuance $ 1   88,499   88,500
Payment in kind interest stock issuance (in shares) 12,378        
Warrants issued for consulting fees     56,788   56,788
Conversion of series convertible preferred to common stock $ 667 $ (20) (647)    
Conversion of series convertible preferred to common stock (in shares) 6,666,666 (200,000)      
Net loss       (4,974,830) (4,974,830)
Balance at ending (in shares) at Mar. 31, 2022 51,169,047        
Balance at ending at Mar. 31, 2022 $ 5,117   72,644,014 (76,091,241) (3,442,110)
Increase (Decrease) in Stockholders' Equity          
Stock-based compensation     1,282,548   1,282,548
Warrants issued in conjunction with debentures     3,036,970   3,036,970
Payment in kind interest stock issuance $ 1   88,497   88,498
Payment in kind interest stock issuance (in shares) 10,773        
Warrants issued for consulting fees     197,226   197,226
Beneficial conversion feature of convertible debenture     2,079,993   2,079,993
Net loss       (5,672,285) (5,672,285)
Balance at ending (in shares) at Jun. 30, 2022 51,179,820        
Balance at ending at Jun. 30, 2022 $ 5,118   79,329,248 (81,763,526) (2,429,160)
Balance at beginning at Sep. 30, 2022 $ 5,638   101,970,318 (96,321,864) 5,654,092
Balance at beginning (in shares) at Sep. 30, 2022 56,381,209        
Increase (Decrease) in Stockholders' Equity          
Stock-based compensation     1,790,807   1,790,807
Net loss       (5,259,439) (5,259,439)
Balance at ending (in shares) at Dec. 31, 2022 56,381,209        
Balance at ending at Dec. 31, 2022 $ 5,638   103,761,125 (101,581,303) 2,185,460
Balance at beginning at Sep. 30, 2022 $ 5,638   101,970,318 (96,321,864) $ 5,654,092
Balance at beginning (in shares) at Sep. 30, 2022 56,381,209        
Increase (Decrease) in Stockholders' Equity          
Shares issued upon exercise of options (in shares)         22,462
Short Swing Profit Recovery         $ (1,201)
Net loss         (22,952,087)
Balance at ending (in shares) at Jun. 30, 2023 59,183,668        
Balance at ending at Jun. 30, 2023 $ 5,918   117,143,464 (119,273,952) (2,124,570)
Balance at beginning at Dec. 31, 2022 $ 5,638   103,761,125 (101,581,303) 2,185,460
Balance at beginning (in shares) at Dec. 31, 2022 56,381,209        
Increase (Decrease) in Stockholders' Equity          
Stock-based compensation     2,475,807   2,475,807
Short Swing Profit Recovery     1,201   1,201
Issuance costs for stock uplist     (86,330)   (86,330)
Net loss       (9,817,117) (9,817,117)
Balance at ending (in shares) at Mar. 31, 2023 56,381,209        
Balance at ending at Mar. 31, 2023 $ 5,638   106,151,803 (111,398,420) (5,240,979)
Increase (Decrease) in Stockholders' Equity          
Shares issued, value $ 278   8,224,782   8,225,060
Number of shares issued during period 2,779,997        
Shares issued upon exercise of options $ 2   38,408   38,410
Shares issued upon exercise of options (in shares) 22,462        
Stock-based compensation     2,547,799   2,547,799
Warrants issued in conjunction with debentures     136,103   136,103
Warrants issued for consulting fees     44,569   44,569
Net loss       (7,875,532) (7,875,532)
Balance at ending (in shares) at Jun. 30, 2023 59,183,668        
Balance at ending at Jun. 30, 2023 $ 5,918   $ 117,143,464 $ (119,273,952) $ (2,124,570)